1. Introduction
1.1 Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Market Insights
2.2 Market Attractiveness
3. Research Methodology
3.1 Secondary Research
3.2 Primary Research
- 3.2.1 Data Triangulation and Validation
4. Asia Pacific Bioproduction Market Landscape
4.1 Overview
4.3 Ecosystem Analysis
- 4.3.1 List of Vendors in the Value Chain
5. Asia Pacific Bioproduction Market – Key Market Dynamics
5.1 Market Drivers
5.2 Market Restraints
5.3 Market Opportunities
5.4 Future Trends
5.5 Impact of Drivers and Restraints
6. Asia Pacific Bioproduction Market Regional Analysis
6.2 Asia Pacific Bioproduction Market Revenue 2020-2030 (US$ Million)
6.3 Asia Pacific Bioproduction Market Forecast Analysis
7. Asia Pacific Bioproduction Market Analysis – by Product
7.1 Biologics and Biosimilars
- 7.1.1 Overview
- 7.1.2 Biologics and Biosimilars: Asia Pacific Bioproduction Market – Revenue and Forecast, 2020-2030 (US$ Million)
7.2 Vaccines
- 7.2.1 Overview
- 7.2.2 Vaccines: Asia Pacific Bioproduction Market – Revenue and Forecast, 2020-2030 (US$ Million)
7.3 Cell and Gene Therapies
- 7.3.1 Overview
- 7.3.2 Cell and Gene Therapies: Asia Pacific Bioproduction Market – Revenue and Forecast, 2020-2030 (US$ Million)
7.4 Nucleic Acid Therapeutics
- 7.4.1 Overview
- 7.4.2 Nucleic Acid Therapeutics: Asia Pacific Bioproduction Market – Revenue and Forecast, 2020-2030 (US$ Million)
8. Asia Pacific Bioproduction Market Analysis – by Application
8.1 Rheumatoid Arthritis
- 8.1.1 Overview
- 8.1.2 Rheumatoid Arthritis: Asia Pacific Bioproduction Market – Revenue and Forecast, 2020-2030 (US$ Million)
8.2 Hematological Disorders
- 8.2.1 Overview
- 8.2.2 Hematological Disorders: Asia Pacific Bioproduction Market – Revenue and Forecast, 2020-2030 (US$ Million)
8.3 Cancer
- 8.3.1 Overview
- 8.3.2 Cancer: Asia Pacific Bioproduction Market – Revenue and Forecast, 2020-2030 (US$ Million)
8.4 Diabetes
- 8.4.1 Overview
- 8.4.2 Diabetes: Asia Pacific Bioproduction Market – Revenue and Forecast, 2020-2030 (US$ Million)
8.5 Cardiovascular Diseases
- 8.5.1 Overview
- 8.5.2 Cardiovascular Diseases: Asia Pacific Bioproduction Market – Revenue and Forecast, 2020-2030 (US$ Million)
9. Asia Pacific Bioproduction Market Analysis – by Equipment
9.1 Upstream Equipment
- 9.1.1 Overview
- 9.1.2 Upstream Equipment: Asia Pacific Bioproduction Market – Revenue and Forecast, 2020-2030 (US$ Million)
9.2 Downstream Equipment
- 9.2.1 Overview
- 9.2.2 Downstream Equipment: Asia Pacific Bioproduction Market – Revenue and Forecast, 2020-2030 (US$ Million)
9.3 Bioreactors
- 9.3.1 Overview
- 9.3.2 Bioreactors: Asia Pacific Bioproduction Market – Revenue and Forecast, 2020-2030 (US$ Million)
9.4 Consumables and Accessories
- 9.4.1 Overview
- 9.4.2 Consumables and Accessories: Asia Pacific Bioproduction Market – Revenue and Forecast, 2020-2030 (US$ Million)
10. Asia Pacific Bioproduction Market Analysis – by End User
10.1 Biopharmaceutical Companies
- 10.1.1 Overview
- 10.1.2 Biopharmaceutical Companies: Asia Pacific Bioproduction Market – Revenue and Forecast, 2020-2030 (US$ Million)
10.2 Contract Manufacturing Organizations
- 10.2.1 Overview
- 10.2.2 Contract Manufacturing Organizations: Asia Pacific Bioproduction Market – Revenue and Forecast, 2020-2030 (US$ Million)
11. Asia Pacific Bioproduction Market – Asia-Pacific Analysis
11.1 Overview
11.2 Asia-Pacific
- 11.2.1 Asia Pacific Bioproduction Market Breakdown, by Key
Country, 2023 and 2030 (%)
- 11.2.1.1 Asia Pacific Bioproduction Market – Revenue and
Forecast Analysis – by Country
- 11.2.1.1 China:
Asia Pacific Bioproduction Market – Revenue and Forecast to 2030 (US$ Million)
- 11.2.1.1.1 China: Asia Pacific Bioproduction Market Breakdown, by Product
- 11.2.1.1.2 China: Asia Pacific Bioproduction Market Breakdown, by Application
- 11.2.1.1.3 China: Asia Pacific Bioproduction Market Breakdown, by Equipment
- 11.2.1.1.4 China: Asia Pacific Bioproduction Market Breakdown, by End User
- 11.2.1.2 India:
Asia Pacific Bioproduction Market – Revenue and Forecast to 2030 (US$ Million)
- 11.2.1.2.1 India: Asia Pacific Bioproduction Market Breakdown, by Product
- 11.2.1.2.2 India: Asia Pacific Bioproduction Market Breakdown, by Application
- 11.2.1.2.3 India: Asia Pacific Bioproduction Market Breakdown, by Equipment
- 11.2.1.2.4 India: Asia Pacific Bioproduction Market Breakdown, by End User
- 11.2.1.3 Japan:
Asia Pacific Bioproduction Market – Revenue and Forecast to 2030 (US$ Million)
- 11.2.1.3.1 Japan: Asia Pacific Bioproduction Market Breakdown, by Product
- 11.2.1.3.2 Japan: Asia Pacific Bioproduction Market Breakdown, by Application
- 11.2.1.3.3 Japan: Asia Pacific Bioproduction Market Breakdown, by Equipment
- 11.2.1.3.4 Japan: Asia Pacific Bioproduction Market Breakdown, by End User
- 11.2.1.4 Australia:
Asia Pacific Bioproduction Market – Revenue and Forecast to 2030 (US$ Million)
- 11.2.1.4.1 Australia: Asia Pacific Bioproduction Market Breakdown, by Product
- 11.2.1.4.2 Australia: Asia Pacific Bioproduction Market Breakdown, by Application
- 11.2.1.4.3 Australia: Asia Pacific Bioproduction Market Breakdown, by Equipment
- 11.2.1.4.4 Australia: Asia Pacific Bioproduction Market Breakdown, by End User
- 11.2.1.5 Rest of Asia-Pacific :
Asia Pacific Bioproduction Market – Revenue and Forecast to 2030 (US$ Million)
- 11.2.1.5.1 Rest of Asia-Pacific : Asia Pacific Bioproduction Market Breakdown, by Product
- 11.2.1.5.2 Rest of Asia-Pacific : Asia Pacific Bioproduction Market Breakdown, by Application
- 11.2.1.5.3 Rest of Asia-Pacific : Asia Pacific Bioproduction Market Breakdown, by Equipment
- 11.2.1.5.4 Rest of Asia-Pacific : Asia Pacific Bioproduction Market Breakdown, by End User
12. Competitive Landscape
12.1 Heat Map Analysis
12.2 Company Positioning and Concentration
13. Industry Landscape
13.1 Overview
13.2 Market Initiative
13.3 Partnerships and Collaborations
13.4 Other Developments
14. Company Profiles
14.1 Lonza Group AG
- 14.1.1 Key Facts
- 14.1.2 Business Description
- 14.1.3 Products and Services
- 14.1.4 Financial Overview
- 14.1.5 SWOT Analysis
- 14.1.6 Key Developments
14.2 bbi-biotech GmbH
- 14.2.1 Key Facts
- 14.2.2 Business Description
- 14.2.3 Products and Services
- 14.2.4 Financial Overview
- 14.2.5 SWOT Analysis
- 14.2.6 Key Developments
14.3 Danaher Corp
- 14.3.1 Key Facts
- 14.3.2 Business Description
- 14.3.3 Products and Services
- 14.3.4 Financial Overview
- 14.3.5 SWOT Analysis
- 14.3.6 Key Developments
14.4 Sartorius AG
- 14.4.1 Key Facts
- 14.4.2 Business Description
- 14.4.3 Products and Services
- 14.4.4 Financial Overview
- 14.4.5 SWOT Analysis
- 14.4.6 Key Developments
14.5 FUJIFILM Irvine Scientific Inc
- 14.5.1 Key Facts
- 14.5.2 Business Description
- 14.5.3 Products and Services
- 14.5.4 Financial Overview
- 14.5.5 SWOT Analysis
- 14.5.6 Key Developments
14.6 Thermo Fisher Scientific Inc
- 14.6.1 Key Facts
- 14.6.2 Business Description
- 14.6.3 Products and Services
- 14.6.4 Financial Overview
- 14.6.5 SWOT Analysis
- 14.6.6 Key Developments
14.7 Merck KGaA
- 14.7.1 Key Facts
- 14.7.2 Business Description
- 14.7.3 Products and Services
- 14.7.4 Financial Overview
- 14.7.5 SWOT Analysis
- 14.7.6 Key Developments
14.8 F. Hoffmann-La Roche Ltd
- 14.8.1 Key Facts
- 14.8.2 Business Description
- 14.8.3 Products and Services
- 14.8.4 Financial Overview
- 14.8.5 SWOT Analysis
- 14.8.6 Key Developments
14.9 Bio-Rad Laboratories Inc
- 14.9.1 Key Facts
- 14.9.2 Business Description
- 14.9.3 Products and Services
- 14.9.4 Financial Overview
- 14.9.5 SWOT Analysis
- 14.9.6 Key Developments
15. Appendix
15.1 About Business Market Insights
15.2 List of Abbreviations